YPSOMED HLDG/ CH0019396990 /
2024-08-14 5:30:45 PM | Chg. -1.00 | Volume | Bid5:55:00 AM | Ask5:55:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
403.00CHF | -0.25% | 6,352 Turnover: 2.58 mill. |
397.00Bid Size: 20 | 410.00Ask Size: 98 | 5.5 bill.CHF | 0.50% | 70.21 |
Assets
|
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
2024 Swiss GAAP FER in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 309.1000 | 334.4000 | 336.2000 | 387.6770 | 445.2910 | ||||||
Intangible Assets | 102.5000 | 160.7000 | 190.8000 | 231.7380 | 281.5760 | ||||||
Long-Term Investments | .2000 | 2.7000 | 2.6000 | 2.6390 | 2.7130 | ||||||
Fixed Assets | 488.4000 | 532.5000 | 563.3000 | 653.5520 | 763.4500 | ||||||
Inventories | 56.3000 | 63.4000 | 68.3000 | 57.7040 | 75.2860 | ||||||
Accounts Receivable | 76.3000 | 72.7000 | 87 | 93.3360 | 128.0310 | ||||||
Cash and Cash Equivalents | 13.4000 | 19.3000 | 17 | 25.2240 | 74.0170 | ||||||
Current Assets | 186.4000 | 185.1000 | 193.6000 | 208.3270 | 337.9450 | ||||||
Total Assets | 674.7000 | 717.7000 | 756.9000 | 861.8790 | 1,101.3950 |
Liabilities
|
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
2024 Swiss GAAP FER in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 24 | 34.6000 | 17.4000 | 19.6200 | 30.8840 | ||||||
Long-term debt | 10 | 32.5000 | 110 | 0.0000 | - | ||||||
Liabilities to Banks | 193 | 215 | 267 | - | - | ||||||
Provisions | 7.3000 | 8.6000 | 9.3000 | 16.1750 | 11.3010 | ||||||
Liabilities | 299.5000 | 322.3000 | 364.4000 | 299.5460 | 483.6590 | ||||||
Share Capital | 179 | 179 | 178.9940 | - | - | ||||||
Total Equity | 375.2000 | 395.4000 | 392.5000 | 562.3330 | 617.7360 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 674.7000 | 717.7000 | 756.9000 | 861.8790 | 1,101.3950 |
Income Statement
|
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
2024 Swiss GAAP FER in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 393.9000 | 403.7000 | 464.8000 | 497.4600 | 548.4570 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 9.3000 | 9.3000 | 28.6000 | 60.5940 | 86.2190 | ||||||
Interest Income | - | - | - | -3.9570 | -4.3480 | ||||||
Income Before Taxes | 7.5000 | 6.1000 | 25.5000 | - | - | ||||||
Income Taxes | 4 | -.3000 | -2.4000 | 5.3620 | 3.5060 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | - | - | 0.0000 | ||||||
Net Income | 11.5000 | 5.8000 | 23.1000 | 51.2750 | 78.3660 |
Per Share
Cash Flow
|
2020 - in mill. CHF |
2021 - in mill. CHF |
2022 - in mill. CHF |
2023 Swiss GAAP FER in mill. CHF |
2024 Swiss GAAP FER in mill. CHF |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 49.1000 | 85.8000 | - | 129.5310 | 163.2240 | ||||||
Cash Flow from Investing Activities | -115.8000 | -106.9000 | - | -122.0190 | -195.0720 | ||||||
Cash Flow from Financing | 68.7000 | 26.7000 | - | 1.2650 | 81.0660 | ||||||
Decrease / Increase in Cash | 1.3000 | 5.9000 | - | - | - | ||||||
Employees | 1,714 | 1,824 | 1,923 | 2,059 | 2,389 |